ASCO-Update 2015 - Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015

S. Lorenzen; D. Arnold; C. Fottner; J. Leichsenring; M. Moehler; T. Seufferlein; A. Vogel; M. M. Weber; A. Reinacher-Schick

doi:10.1055/s-0041-111632

ASCO-Update 2015 - Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015

Translated title of the contribution: ASCO-update 2015 - Highlights of the 51. Meeting of the American Society of clinical oncology/ASCO 2015

S. Lorenzen
, D. Arnold
, C. Fottner
, J. Leichsenring
, M. Moehler
, T. Seufferlein
, A. Vogel
, M. M. Weber
, A. Reinacher-Schick

Department of Surgery

Klinik für Tumorbiologie
Johannes Gutenberg University
Max-Planck-lnstitut für Kohlenforschung
University Medical Center
University Medical Center Ulm and Center of Excellence 'Metabolic Disorders'
Klinik für Gastroenterologie, Hepatologie und Endokrinologie

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The field of gastrointestinal oncology is rapidly developing, on the one hand through the identification of novel molecular targets and therapeutic principles, on the other hand through the establishment and improvement of multidisciplinary treatment strategies. The following manuscript summarizes the most important trial results of the ASCO Meeting 2015 for gastrointestinal cancers. Besides trials on perioperative treatment of esophageal-, pancreatic- and colon cancer, we will present impressive data on new therapeutic strategies such as immunotherapy in gastric-, liver and microsatellite instable colorectal cancer. The trials will be put into context by the authors.

Translated title of the contribution	ASCO-update 2015 - Highlights of the 51. Meeting of the American Society of clinical oncology/ASCO 2015
Original language	German
Pages (from-to)	167-172
Number of pages	6
Journal	Zeitschrift fur Gastroenterologie
Volume	54
Issue number	2
DOIs	https://doi.org/10.1055/s-0041-111632
State	Published - 1 Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1055/s-0041-111632

Cite this

@article{ed4efc30cb8744bcac2dd8480b38a97f,

title = "ASCO-Update 2015 - Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015",

abstract = "The field of gastrointestinal oncology is rapidly developing, on the one hand through the identification of novel molecular targets and therapeutic principles, on the other hand through the establishment and improvement of multidisciplinary treatment strategies. The following manuscript summarizes the most important trial results of the ASCO Meeting 2015 for gastrointestinal cancers. Besides trials on perioperative treatment of esophageal-, pancreatic- and colon cancer, we will present impressive data on new therapeutic strategies such as immunotherapy in gastric-, liver and microsatellite instable colorectal cancer. The trials will be put into context by the authors.",

keywords = "colorectal cancer, esophageal cancer, gastric cancer, hepatobiliary cancer, neuroendocrine tumors, pancreatic cancer",

author = "S. Lorenzen and D. Arnold and C. Fottner and J. Leichsenring and M. Moehler and T. Seufferlein and A. Vogel and Weber, \{M. M.\} and A. Reinacher-Schick",

year = "2016",

month = feb,

day = "1",

doi = "10.1055/s-0041-111632",

language = "Deutsch",

volume = "54",

pages = "167--172",

journal = "Zeitschrift fur Gastroenterologie",

issn = "0044-2771",

publisher = "Georg Thieme Verlag",

number = "2",

}

TY - JOUR

T1 - ASCO-Update 2015 - Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015

AU - Lorenzen, S.

AU - Arnold, D.

AU - Fottner, C.

AU - Leichsenring, J.

AU - Moehler, M.

AU - Seufferlein, T.

AU - Vogel, A.

AU - Weber, M. M.

AU - Reinacher-Schick, A.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The field of gastrointestinal oncology is rapidly developing, on the one hand through the identification of novel molecular targets and therapeutic principles, on the other hand through the establishment and improvement of multidisciplinary treatment strategies. The following manuscript summarizes the most important trial results of the ASCO Meeting 2015 for gastrointestinal cancers. Besides trials on perioperative treatment of esophageal-, pancreatic- and colon cancer, we will present impressive data on new therapeutic strategies such as immunotherapy in gastric-, liver and microsatellite instable colorectal cancer. The trials will be put into context by the authors.

AB - The field of gastrointestinal oncology is rapidly developing, on the one hand through the identification of novel molecular targets and therapeutic principles, on the other hand through the establishment and improvement of multidisciplinary treatment strategies. The following manuscript summarizes the most important trial results of the ASCO Meeting 2015 for gastrointestinal cancers. Besides trials on perioperative treatment of esophageal-, pancreatic- and colon cancer, we will present impressive data on new therapeutic strategies such as immunotherapy in gastric-, liver and microsatellite instable colorectal cancer. The trials will be put into context by the authors.

KW - colorectal cancer

KW - esophageal cancer

KW - gastric cancer

KW - hepatobiliary cancer

KW - neuroendocrine tumors

KW - pancreatic cancer

UR - https://www.scopus.com/pages/publications/84957795594

U2 - 10.1055/s-0041-111632

DO - 10.1055/s-0041-111632

M3 - Artikel

C2 - 26854837

AN - SCOPUS:84957795594

SN - 0044-2771

VL - 54

SP - 167

EP - 172

JO - Zeitschrift fur Gastroenterologie

JF - Zeitschrift fur Gastroenterologie

IS - 2

ER -

ASCO-Update 2015 - Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this